GlassScriptPhysician profile
Kali Stidham
NPI 1497456719
$4,740.89
in general payments reported to CMS, 2019-2025
27 companies · $2,493 in 2025
The $2,493 reported for 2025 was more than what 97% of Family providers received nationally (typical 2025 total: $167).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2023: $1,007 · 2024: $1,241 · 2025: $2,493.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $4,412 · Education: $329.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $4,411.91 |
| Education | $328.98 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Sumitomo Pharma America, INC. | $1,406.12 | 2023-2025 | Orgovyx, Gemtesa |
| Astellas Pharma US INC | $499.45 | 2023-2025 | Xtandi, Myrbetriq |
| Blue Earth Diagnostics | $404.68 | 2023-2024 | |
| Pfizer INC. | $297.99 | 2023-2025 | |
| Janssen Biotech, INC. | $297.00 | 2023-2025 | Erleada, Rybrevant, Carvykti |
| Antares Pharma, INC. | $296.73 | 2023-2025 | Xyosted, Nocdurna, Tlando |
| Olympus America INC. | $208.38 | 2025 | Itind System |
| Medtronic, INC. | $156.63 | 2023 | Interstim |
| Bayer Healthcare Pharmaceuticals INC. | $140.73 | 2025 | |
| 180 Medical, INC. | $121.00 | 2025 | |
| Boston Scientific Corporation | $115.98 | 2024-2025 | Spaceoar Vue System - 10ml, Ams 800 Artificial Urinary Sphincter |
| Urogen Pharma, INC. | $111.90 | 2024-2025 | |
| Verity Pharmaceuticals INC. | $99.58 | 2025 | Trelstar, Tlando |
| Immunitybio, INC. | $99.34 | 2024-2025 | |
| Seagen INC. | $84.99 | 2025 |
Show all 27 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Endo USA, INC. | $73.59 | 2025 | Xiaflex, Aveed |
| Tolmar, INC. | $69.34 | 2025 | Jatenzo, Eligard |
| Progenics Pharmaceuticals, INC. | $62.88 | 2023-2025 | Pylarify |
| Halozyme INC | $35.88 | 2023 | |
| Teleflex LLC | $29.17 | 2023 | Urolift |
| Merck Sharp & Dohme LLC | $22.23 | 2025 | |
| Astrazeneca Pharmaceuticals LP | $20.75 | 2025 | Lynparza |
| Foundation Medicine, INC. | $18.93 | 2023 | Foundationone Liquid Cdx |
| Dendreon Pharmaceuticals LLC | $18.90 | 2025 | Provenge |
| C. R. Bard, INC. & Subsidiaries | $18.43 | 2025 | Personal Catheter Intermittent Catheter |
| Avanos Medical | $16.61 | 2024 | On-Q* Pump and Accessories |
| Abbvie INC. | $13.68 | 2024 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Kali Stidham listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.